Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial

Mats Jerkeman; Arne Kolstad; Martin Hutchings; Annika Pasanen; Leo Meriranta; Carsten Utoft Niemann; Rasmus Rask Kragh Jorgensen; Tarec Christoffer Christoffer El-Galaly; Jon Riise; Sirpa Leppä; Jacob Haaber Christensen; Karin Fahl Wader; Ingrid Glimelius

doi:10.1182/blood-2022-155654

Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial

Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jorgensen, Tarec Christoffer Christoffer El-Galaly, Jon Riise, Sirpa Leppä , Jacob Haaber Christensen, Karin Fahl Wader, Ingrid Glimelius

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	623
Journal	Blood
Volume	140
Issue number	Suppl. 1
Pages (from-to)	184–185
Number of pages	2
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2022-155654
Publication status	Published - 15 Nov 2022
Event	64th ASH Annual Meeting & Exposition - Ernest N. Morial Convention or virtually, New Orleans, United States Duration: 10 Dec 2022 → 13 Dec 2022

Conference

Conference	64th ASH Annual Meeting & Exposition
Location	Ernest N. Morial Convention or virtually
Country/Territory	United States
City	New Orleans
Period	10/12/2022 → 13/12/2022

Bibliographical note

Abstract No. 623

Access to Document

10.1182/blood-2022-155654

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Jerkeman, M., Kolstad, A., Hutchings, M., Pasanen, A., Meriranta, L., Niemann, C. U., Jorgensen, R. R. K., El-Galaly, T. C. C., Riise, J., Leppä , S., Christensen, J. H., Wader, K. F., & Glimelius, I. (2022). Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial. Blood, 140(Suppl. 1), 184–185. Article 623. https://doi.org/10.1182/blood-2022-155654

@article{bc6618ebcade4a639961a4be4759051d,

title = "Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial",

author = "Mats Jerkeman and Arne Kolstad and Martin Hutchings and Annika Pasanen and Leo Meriranta and Niemann, {Carsten Utoft} and Jorgensen, {Rasmus Rask Kragh} and El-Galaly, {Tarec Christoffer Christoffer} and Jon Riise and Sirpa Lepp{\"a} and Christensen, {Jacob Haaber} and Wader, {Karin Fahl} and Ingrid Glimelius",

note = "Abstract No. 623; 64th ASH Annual Meeting & Exposition, ASH 2022 ; Conference date: 10-12-2022 Through 13-12-2022",

year = "2022",

month = nov,

day = "15",

doi = "10.1182/blood-2022-155654",

language = "English",

volume = "140",

pages = "184–185",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "Suppl. 1",

}

Jerkeman, M, Kolstad, A, Hutchings, M, Pasanen, A, Meriranta, L, Niemann, CU, Jorgensen, RRK , El-Galaly, TCC, Riise, J, Leppä , S, Christensen, JH, Wader, KF & Glimelius, I 2022, 'Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial', Blood, vol. 140, no. Suppl. 1, 623, pp. 184–185. https://doi.org/10.1182/blood-2022-155654

Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial. / Jerkeman, Mats; Kolstad, Arne; Hutchings, Martin et al.
In: Blood, Vol. 140, No. Suppl. 1, 623, 15.11.2022, p. 184–185.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial

AU - Jerkeman, Mats

AU - Kolstad, Arne

AU - Hutchings, Martin

AU - Pasanen, Annika

AU - Meriranta, Leo

AU - Niemann, Carsten Utoft

AU - Jorgensen, Rasmus Rask Kragh

AU - El-Galaly, Tarec Christoffer Christoffer

AU - Riise, Jon

AU - Leppä , Sirpa

AU - Christensen, Jacob Haaber

AU - Wader, Karin Fahl

AU - Glimelius, Ingrid

N1 - Abstract No. 623

PY - 2022/11/15

Y1 - 2022/11/15

U2 - 10.1182/blood-2022-155654

DO - 10.1182/blood-2022-155654

M3 - Conference abstract in journal

SN - 0006-4971

VL - 140

SP - 184

EP - 185

JO - Blood

JF - Blood

IS - Suppl. 1

M1 - 623

T2 - 64th ASH Annual Meeting & Exposition

Y2 - 10 December 2022 through 13 December 2022

ER -